Journal article
Minimal expression of dysferlin prevents development of dysferlinopathy in dysferlin exon 40a knockout mice
J Yasa, CE Reed, AM Bournazos, FJ Evesson, I Pang, ME Graham, JR Wark, B Nijagal, KH Kwan, T Kwiatkowski, R Jung, N Weisleder, ST Cooper, FA Lemckert
Acta Neuropathologica Communications | BMC | Published : 2023
Abstract
Dysferlin is a Ca2+-activated lipid binding protein implicated in muscle membrane repair. Recessive variants in DYSF result in dysferlinopathy, a progressive muscular dystrophy. We showed previously that calpain cleavage within a motif encoded by alternatively spliced exon 40a releases a 72 kDa C-terminal minidysferlin recruited to injured sarcolemma. Herein we use CRISPR/Cas9 gene editing to knock out murine Dysf exon 40a, to specifically assess its role in membrane repair and development of dysferlinopathy. We created three Dysf exon 40a knockout (40aKO) mouse lines that each express different levels of dysferlin protein ranging from ~ 90%, ~ 50% and ~ 10–20% levels of wild-type. Histopath..
View full abstractGrants
Awarded by Cancer Institute NSW
Funding Acknowledgements
This work was supported through a National Health and Medical Research Council (NHMRC) Project Grant APP1103618 (STC) and Jain Foundation grant (FL). Sandra T. Cooper is supported by a NHMRC of Australia Senior Research Fellowship APP1136197.